The company's stock has zoomed this year, driven by the explosive growth of the weight-loss drug market.
The company’s stock has zoomed this year, driven by the explosive growth of the weight-loss drug market.
By Reuters
Share
Save
Save articles to read later and create your own reading list.
Eli Lilly 1st health company to hit $1 trillion in value - UPI.com
Eli Lilly tops $1 trillion — plus, how a Fed head threw the market a lifeline
Eli Lilly entra nel club dei mille miliardi: record per una big pharma grazie agli anti-obesità
Sentiremo parlare sempre più spesso di questa azienda farmaceutica - Il Post
Why Eli Lilly will win the GLP-1 race – plus, a promising sign for Boeing investors
Novo Nordisk stumbles against Eli Lilly in GLP-1 drug battle. Which stock is the best buy from here?
